Gelesis Holdings, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GLS research report →
About the company
Gelesis Holdings Inc. is a biopharmaceutical company actively marketing products, dedicated to creating biomimetic solutions that target the underlying causes of obesity and chronic gastrointestinal conditions. Among its key offerings is PLENITY, an oral therapeutic designed for weight management that is non-stimulant and does not enter the bloodstream.
- CEO
- Yishai Zohar
- IPO
- 2022
- Employees
- 93
- HQ
- Boston, MA, US
Price Chart
- Market Cap
- $11.63M
- P/E
- -0.20
- P/S
- 0.45
- P/B
- -0.44
- EV/EBITDA
- -0.55
- Div Yield
- 0.00%
- Gross Margin
- -6.95%
- Op Margin
- -472.72%
- Net Margin
- -216.48%
- ROE
- 31.43%
- ROIC
- -137.49%
- Revenue
- $25.77M · 130.37%
- Net Income
- $-55,780,000 · 40.24%
- EPS
- $-0.79 · 95.17%
- Op Income
- $-121,806,000
- FCF YoY
- -15.48%
- 52W High
- $5.67
- 52W Low
- $0.01
- 50D MA
- $0.18
- 200D MA
- $0.61
- Beta
- 0.99
- Avg Volume
- 570.67K
Get TickerSpark's AI analysis on GLS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Sep 20, 23 | PureTech Health plc | buy | 0 |
| Jun 12, 23 | PureTech Health plc | buy | 0 |
| May 26, 23 | PureTech Health plc | buy | 43,133,803 |
| May 26, 23 | PureTech Health plc | buy | 0 |
| May 1, 23 | PureTech Health plc | buy | 192,307,692 |
| May 1, 23 | PureTech Health plc | buy | 23,688,047 |
| May 1, 23 | PureTech Health plc | buy | 5,000,000 |
| May 1, 23 | PureTech Health plc | buy | 2,000,000 |
| Nov 21, 22 | KUCHERLAPATI RAJU S | buy | 92,000 |
| Nov 18, 22 | KUCHERLAPATI RAJU S | buy | 8,000 |
Our GLS coverage
Recent articles, reports, and earnings notes.
No research on GLS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate GLS report →Similar companies
Peers in the same neighborhood.